PofoliaShared via Pofolia

Clinical Infectious Diseases· 2016Q1

<i>Nocardia</i>Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study

Julien Coussement, for the European Study Group for Nocardia in Solid Organ Transplantation, David Lebeaux, for the European Study Group for Nocardia in Solid Organ Transplantation et al.

Short summary

This study identified five key risk factors for nocardiosis, a rare but serious infection, in solid organ transplant recipients: high calcineurin inhibitor levels, tacrolimus use, higher corticosteroid doses, older patient age, and longer ICU stays post-transplant.

AI-generated from the title and abstract; the full text is not read.

Key points

  • High calcineurin inhibitor trough levels are a major risk factor (OR 6.11) for nocardiosis post-SOT.
  • Tacrolimus use, higher corticosteroid doses, older age, and longer ICU stays also increase risk.
  • Low-dose cotrimoxazole prophylaxis was ineffective in preventing nocardiosis.
  • Nocardia farcinica was more often linked to brain, skin, and subcutaneous infections.
  • Over 43% of patients with central nervous system nocardiosis had no neurological symptoms.

AI-generated from the title and abstract; the full text is not read.

Abstract

BACKGROUND: Nocardiosis is a rare, life-threatening opportunistic infection, affecting 0.04% to 3.5% of patients after solid organ transplant (SOT). The aim of this study was to identify risk factors for Nocardia infection after SOT and to describe the presentation of nocardiosis in these patients. METHODS: We performed a retrospective case-control study of adult patients diagnosed with nocardiosis after SOT between 2000 and 2014 in 36 European (France, Belgium, Switzerland, the Netherlands, Spain) centers. Two control subjects per case were matched by institution, transplant date, and transplanted organ. A multivariable analysis was performed using conditional logistic regression to identify risk factors for nocardiosis. RESULTS: One hundred and seventeen cases of nocardiosis and 234 control patients were included. Nocardiosis occurred at a median of 17.5 (range, 2-244) months after transplant. In multivariable analysis, high calcineurin inhibitor trough levels in the month before diagnosis (odds ratio [OR], 6.11; 95% confidence interval [CI], 2.58-14.51), use of tacrolimus (OR, 2.65; 95% CI, 1.17-6.00) and corticosteroid dose (OR, 1.12; 95% CI, 1.03-1.22) at the time of diagnosis, patient age (OR, 1.04; 95% CI, 1.02-1.07), and length of stay in the intensive care unit after SOT (OR, 1.04; 95% CI, 1.00-1.09) were independently associated with development of nocardiosis; low-dose cotrimoxazole prophylaxis was not found to prevent nocardiosis. Nocardia farcinica was more frequently associated with brain, skin, and subcutaneous tissue infections than were other Nocardia species. Among the 30 cases with central nervous system nocardiosis, 13 (43.3%) had no neurological symptoms. CONCLUSIONS: We identified 5 risk factors for nocardiosis after SOT. Low-dose cotrimoxazole was not found to prevent Nocardia infection. These findings may help improve management of transplant recipients.

The authors' abstract, as published at the source. Clinical Infectious Diseases, 2016 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Microbiology

MicrobiologyMedicine